
Strategic biopharmaceutical leader with 10+ years of experience and deep technical expertise in analytical method development, including HPLC, UPLC, CE-SDS analysis, qPCR, ddPCR, Potency, TCID50, ELISA, Octet (BLI), AUC, and a broad range of analytical methods for process and product characterization. Proven track record in method development, transfers, and validation with technical excellence, and leading cross-functional collaborations working with CDMO/CRO/CTO. Adept at driving biologics & gene therapy programs from development to clinical stages. Recognized for leadership, analytical problem-solving, team management and authoring IND/CTA/BLA documentation and relevant CMC sections.